Möchten Sie immer auf dem neuesten Stand bleiben?

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Biopharmaceutical CMO and CRO Market Report 2026" has been added to ResearchAndMarkets.com's offering. The biopharmaceutical Contract...

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Topical Drugs Contract Development and Manufacturing Organization (CDMO) Market Report 2026" has been added to ResearchAndMarkets.com's offering. ...

Brad Saar joins Sonablate board to support growth of non-invasive prostate cancer treatment to signal next phase of expansion for HIFU-based prostate care.

Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "AI in Predictive Toxicology Market Report 2026" has been added to ResearchAndMarkets.com's offering. The artificial intelligence (AI) in...

Denovo Announces Issuance of U.S. Patent of Novel Genetic Biomarker ANK3 (DGM4™) for Liafensine (DB104)

Dublin, April 28, 2026 (GLOBE NEWSWIRE) -- The "Biosimulation Market (2025 Edition)" report has been added to ResearchAndMarkets.com's offering. The growth of this Market is expected to be...

Grand Cayman, Cayman Islands, April 28, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA...

Dublin, April 22, 2026 (GLOBE NEWSWIRE) -- The "Biosimulation Market by Product & Service, Application, and End User - Global Forecast to 2036" report has been added to ResearchAndMarkets.com's...

Vista, CA, April 22, 2026 (GLOBE NEWSWIRE) -- Mindera Health, a leader in precision medicine for dermatological conditions, today announced it has received approval from the New York State...

CAMBRIDGE, UK — April 21, 2026 — Panakeia (“the Company”), the world’s first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for...